Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond

Cancer Research

Volumn 67, Issue 8, 2007, Pages 3898-3903

  Cohen, Cyrille J ^a   Li, Yong F ^a   El Gamil, Mona ^a   Robbins, Paul F ^a   Rosenberg, Steven A ^a   Morgan, Richard A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; T LYMPHOCYTE RECEPTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CD4+ T LYMPHOCYTE; CELL ACTIVITY; CYTOKINE RELEASE; CYTOLYSIS; DISULFIDE BOND; GENE TRANSFER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR CELL;

CYSTEINE; GENE THERAPY; HUMANS; IMMUNOTHERAPY, ADOPTIVE; JURKAT CELLS; LEUKOCYTES, MONONUCLEAR; MELANOMA; PROTEIN ENGINEERING; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 34248595961     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-3986     Document Type: Article

References (18)

1. Dudley ME, Wunderlich JR, Bobbins PF, et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 2002;298:850-4.
2. Morgan RA, Dudley ME, Wunderlich JR, et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 2006;314:126-9.
3. Cohen CJ, Zhao Y, Zheng Z, Rosenberg SA, Morgan RA. Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability. Cancer Res 2006;66:8878-86.
4. Boulter JM, Glick M, Todorov PT, et al. Stable, soluble T-cell receptor molecules for crystallization and therapeutics. Protein Eng 2003;16:707-11.
5. Topalian SL, Solomon D, Rosenberg SA. Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. J Immunol 1989;142:3714-25.
6. Zhao Y, Zheng Z, Cohen CJ, et al. High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation. Mol Ther 2006;13:151-9.
7. Arnaud J, Huchenq A, Vernhes MC, et al. The interchain disulfide bond between TCR alpha beta heterodimers on human T cells is not required for TCR-CD3 membrane expression and signal transduction. Int Immunol 1997;9:615-26.
8. Li Z, Wu W, Kemp O, Stephen M, Manolios N. The interchain disulfide linkage of T-cell antigen receptor-alpha and -beta chains is a prerequisite for T-cell activation. Cell Immunol 1998;190:101-11.
9. Johnson LA, Heemskerk B, Powell D, et al. Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cell and tumor-infiltrating lymphocytes. J Immunol 2006;177:6548-59.
10. Cohen CJ, Zheng Z, Bray R, et al. Recognition of fresh human tumor by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine anti-p53 TCR. J Immunol 2005;175:5799-808.
11. Ho WY, Yee C, Greenberg PD. Adoptive therapy with CD8(+) T cells: it may get by with a little help from its friends. J Clin Invest 2002;110:1415-7.
12. Stanislawski T, Voss RH, Lotz C, et al. Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer. Nat Immunol 2001;2:962-70.
13. + melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor. Cancer Res 2005;65:1570-6.
14. Li ZG, Wu WP, Manolios N. Structural mutations in the constant region of the T-cell antigen receptor (TCR)beta chain and their effect on TCR alpha and beta chain interaction. Immunology 1996;88:524-30.
15. Heemskerk MH, Hagedoorn RS, van der Hoorn MA, et al. Efficiency of T-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex Blood 2007;109:235-43.
16. SantAngelo DB, Cresswell P, Janeway CA, Jr., Denzin LK. Maintenance of TCR clonality in T cells expressing genes for two TCR heterodimers. Proc Natl Acad Sci U S A 2001;98:6824-9.
17. Viola A, Lanzavecchia A. T cell activation determined by T cell receptor number and tunable thresholds. Science 1996;273:104-6.
18. Lefranc M-P, Lefranc G. The T-cell receptor facts book. London: Academic Press; 2001.